Evommune EVMN Stock Issued During Period Value Deferred Offering Cost
Stock Issued During Period Value Deferred Offering Cost at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:StockIssuedDuringPeriodValueDeferredOfferingCost.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's stock issued during period value deferred offering cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's stock issued during period value deferred offering cost?
- Evommune (EVMN) reported stock issued during period value deferred offering cost of $577.47K in Q4 2025.
- What does stock issued during period value deferred offering cost mean?
- The value of equity issued to cover costs associated with deferred financing or offering activities, such as legal, accounting, or underwriting fees. This metric tracks the use of shares as a form of payment for capital-raising services. It provides insight into the company's strategy for managing transaction-related expenses without depleting cash.